Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion type Assertion NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_head.
- NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion description "[However, a recent breakthrough indicates clinical efficacy of a drug stimulating the metabotropic glutamate receptor II, LY2140023, which has improved efficacy for negative and cognitive symptoms of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion evidence source_evidence_literature NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion SIO_000772 18759551 NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion wasDerivedFrom befree-20140225 NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion wasGeneratedBy ECO_0000203 NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.